MENU
RGEN
AS OF
Dec 24 closing price
Price
$165.66
Change
-$0.70 (-0.42%)
Capitalization
9.33B
62 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
RGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Repligen (RGEN) Ownership - Who owns Repligen?

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
1783
Web
https://www.repligen.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
9.33B
P/E Ratio
8283.00
Total Cash
748.75M
Projected Growth
N/A
Total Debt
688.87M
Revenue
707.89M
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash/Share
13.30
Total Debt/Equity
N/A
Revenue/Share
12.60 USD as % of share price

Fundamentals

RGEN
Capitalization
9.33B
P/E Ratio
8283.00
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash
749M
Total Cash/Share
13.30
Total Debt
689M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
12.60%
Revenue
708M
ROE
N/A
Book Value
2.08B
P/B Ratio
4.48
Cash Flow
N/A
Earnings
0.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
563K
Current Ratio
8.36
Current Revenue Per Employee
106189.54
Dividends Per Share - Security
N/A
EBITDA
121M
Float
N/A
Float - Current
N/A
Gross Income Margin
53.24
Revenue To Assets
0.06
Shares Held By Institutions
18.9B
Shares Outstanding - Current
56.3M
Total Liabilities
841M
Total Volume MTD
N/A
Value
-1
Gain YTD
15.090
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Search For DipsSearch For Dips
Annualized Return+49%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
RGEN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGEN showed earnings on October 28, 2025. You can read more about the earnings report here.
View AI-Driven Trading for RGEN
A.I. Advisor
published General Information

General Information

a developer of biologic drugs

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
1783
Web
https://www.repligen.com